{"entity":{"type":"insider","cik":"0001443705","url":"/insider/0001443705","json_url":"/insider/0001443705.json","name":"Harford Simon N.R.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":19,"first":"2020-01-14","last":"2023-01-23","span_basis":"filed_date"},"name_variants":[{"name":"Harford Simon N.R.","source":"filing","n_filings":19,"first_seen":"2020-01-14","last_seen":"2023-01-23"}],"transactions":[{"id":7916590,"accession":"0001209191-23-004453","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004453","line_url":"/filing/0001209191-23-004453#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102.0,"shares_display":"102","price_per_share":43.8,"price_display":"43.80","price_state":"stated","total_value":4467.6,"total_display":"4,467.60","total_whole":"4,468","shares_owned_after":32689.0,"shares_owned_after_display":"32,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-23","scope":"insider"},{"id":8069952,"accession":"0001209191-23-004219","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004219","line_url":"/filing/0001209191-23-004219#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1776.0,"shares_display":"1,776","price_per_share":43.8,"price_display":"43.80","price_state":"stated","total_value":77788.8,"total_display":"77,788.80","total_whole":"77,789","shares_owned_after":32791.0,"shares_owned_after_display":"32,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-19","filed_date":"2023-01-20","scope":"insider"},{"id":6518103,"accession":"0001209191-22-054487","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054487","line_url":"/filing/0001209191-22-054487#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104.0,"shares_display":"104","price_per_share":19.5764,"price_display":"19.58","price_state":"stated","total_value":2035.9456,"total_display":"2,035.95","total_whole":"2,036","shares_owned_after":33295.0,"shares_owned_after_display":"33,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-24","filed_date":"2022-10-25","scope":"insider"},{"id":6894132,"accession":"0001209191-22-053556","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-053556","line_url":"/filing/0001209191-22-053556#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80.0,"shares_display":"80","price_per_share":23.7858,"price_display":"23.79","price_state":"stated","total_value":1902.864,"total_display":"1,902.86","total_whole":"1,903","shares_owned_after":33399.0,"shares_owned_after_display":"33,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-11","filed_date":"2022-10-13","scope":"insider"},{"id":6753155,"accession":"0001209191-22-043106","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-043106","line_url":"/filing/0001209191-22-043106#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106.0,"shares_display":"106","price_per_share":24.6713,"price_display":"24.67","price_state":"stated","total_value":2615.1578,"total_display":"2,615.16","total_whole":"2,615","shares_owned_after":33479.0,"shares_owned_after_display":"33,479","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-22","filed_date":"2022-07-25","scope":"insider"},{"id":6277010,"accession":"0001209191-22-042038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-042038","line_url":"/filing/0001209191-22-042038#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95.0,"shares_display":"95","price_per_share":24.0276,"price_display":"24.03","price_state":"stated","total_value":2282.622,"total_display":"2,282.62","total_whole":"2,283","shares_owned_after":33585.0,"shares_owned_after_display":"33,585","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-12","filed_date":"2022-07-13","scope":"insider"},{"id":6779430,"accession":"0001209191-22-025525","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-025525","line_url":"/filing/0001209191-22-025525#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103.0,"shares_display":"103","price_per_share":32.9247,"price_display":"32.92","price_state":"stated","total_value":3391.2441,"total_display":"3,391.24","total_whole":"3,391","shares_owned_after":33680.0,"shares_owned_after_display":"33,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-22","filed_date":"2022-04-25","scope":"insider"},{"id":6295859,"accession":"0001209191-22-023974","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-023974","line_url":"/filing/0001209191-22-023974#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":96.0,"shares_display":"96","price_per_share":35.7439,"price_display":"35.74","price_state":"stated","total_value":3431.4144,"total_display":"3,431.41","total_whole":"3,431","shares_owned_after":33783.0,"shares_owned_after_display":"33,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-11","scope":"insider"},{"id":6142693,"accession":"0001209191-22-004807","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-004807","line_url":"/filing/0001209191-22-004807#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":416.0,"shares_display":"416","price_per_share":24.8822,"price_display":"24.88","price_state":"stated","total_value":10350.9952,"total_display":"10,351.00","total_whole":"10,351","shares_owned_after":33879.0,"shares_owned_after_display":"33,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-24","filed_date":"2022-01-25","scope":"insider"},{"id":6722154,"accession":"0001209191-22-002923","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-002923","line_url":"/filing/0001209191-22-002923#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":111.0,"shares_display":"111","price_per_share":25.9464,"price_display":"25.95","price_state":"stated","total_value":2880.0504,"total_display":"2,880.05","total_whole":"2,880","shares_owned_after":12695.0,"shares_owned_after_display":"12,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-11","filed_date":"2022-01-11","scope":"insider"},{"id":4487348,"accession":"0001209191-21-060216","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-060216","line_url":"/filing/0001209191-21-060216#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":93.0,"shares_display":"93","price_per_share":30.2339,"price_display":"30.23","price_state":"stated","total_value":2811.7527,"total_display":"2,811.75","total_whole":"2,812","shares_owned_after":12614.0,"shares_owned_after_display":"12,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-11","filed_date":"2021-10-12","scope":"insider"},{"id":4181878,"accession":"0001209191-21-046787","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-046787","line_url":"/filing/0001209191-21-046787#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":98.0,"shares_display":"98","price_per_share":35.02,"price_display":"35.02","price_state":"stated","total_value":3431.96,"total_display":"3,431.96","total_whole":"3,432","shares_owned_after":12707.0,"shares_owned_after_display":"12,707","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-13","filed_date":"2021-07-15","scope":"insider"},{"id":4891752,"accession":"0001209191-21-026661","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-026661","line_url":"/filing/0001209191-21-026661#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92.0,"shares_display":"92","price_per_share":32.1194,"price_display":"32.12","price_state":"stated","total_value":2954.9848,"total_display":"2,954.98","total_whole":"2,955","shares_owned_after":12196.0,"shares_owned_after_display":"12,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-12","filed_date":"2021-04-14","scope":"insider"},{"id":9271370,"accession":"0001209191-21-005142","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-005142","line_url":"/filing/0001209191-21-005142#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110.0,"shares_display":"110","price_per_share":37.3322,"price_display":"37.33","price_state":"stated","total_value":4106.542,"total_display":"4,106.54","total_whole":"4,107","shares_owned_after":4614.0,"shares_owned_after_display":"4,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-25","scope":"insider"},{"id":4137184,"accession":"0001209191-21-003412","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-003412","line_url":"/filing/0001209191-21-003412#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110.0,"shares_display":"110","price_per_share":37.3322,"price_display":"37.33","price_state":"stated","total_value":4106.542,"total_display":"4,106.54","total_whole":"4,107","shares_owned_after":4614.0,"shares_owned_after_display":"4,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-13","scope":"insider"},{"id":2588281,"accession":"0001209191-20-054623","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-054623","line_url":"/filing/0001209191-20-054623#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90.0,"shares_display":"90","price_per_share":37.3,"price_display":"37.30","price_state":"stated","total_value":3357.0,"total_display":"3,357.00","total_whole":"3,357","shares_owned_after":4616.0,"shares_owned_after_display":"4,616","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-12","filed_date":"2020-10-13","scope":"insider"},{"id":2247560,"accession":"0001209191-20-042210","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-042210","line_url":"/filing/0001209191-20-042210#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92.0,"shares_display":"92","price_per_share":25.56,"price_display":"25.56","price_state":"stated","total_value":2351.52,"total_display":"2,351.52","total_whole":"2,352","shares_owned_after":4706.0,"shares_owned_after_display":"4,706","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-10","filed_date":"2020-07-10","scope":"insider"},{"id":2246133,"accession":"0001209191-20-024284","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-024284","line_url":"/filing/0001209191-20-024284#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97.0,"shares_display":"97","price_per_share":16.52,"price_display":"16.52","price_state":"stated","total_value":1602.44,"total_display":"1,602.44","total_whole":"1,602","shares_owned_after":4798.0,"shares_owned_after_display":"4,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-13","filed_date":"2020-04-13","scope":"insider"},{"id":3233401,"accession":"0001209191-20-003299","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-003299","line_url":"/filing/0001209191-20-003299#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001443705","owner_name":"Harford Simon N.R.","owner_display_name":"Harford Simon N.R.","owner_url":"/insider/0001443705","role":"Officer (CFO and Treasurer)","role_mark":"O","role_mark_label":"Officer (CFO and Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105.0,"shares_display":"105","price_per_share":27.2,"price_display":"27.20","price_state":"stated","total_value":2856.0,"total_display":"2,856.00","total_whole":"2,856","shares_owned_after":4895.0,"shares_owned_after_display":"4,895","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-10","filed_date":"2020-01-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001322505","name":"ALBIREO PHARMA, INC.","url":"/issuer/0001322505","role":"Officer (CFO and Treasurer)","n_filings":19,"first_seen":"2020-01-14","last_seen":"2023-01-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001443705","retrieved_at":"2026-08-25T18:49:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}